Treatment.com AI Completes Acquisition of Rocket Doctor Inc.

Treatment.com International ( (TSE:TRUE) ) has issued an announcement.

Treatment.com AI Inc. has successfully completed the acquisition of Rocket Doctor Inc., a company that empowers doctors to establish virtual practices, thereby enhancing access to medical care. This strategic acquisition is expected to integrate Treatment.com’s AI capabilities, such as the AI Nurse, to improve patient triage and onboarding, potentially boosting the company’s market position and offering proof of concept for future software sales.

Spark’s Take on TSE:TRUE Stock

According to Spark, TipRanks’ AI Analyst, TSE:TRUE is a Underperform.

Treatment.com faces substantial financial issues, including ongoing losses and negative cash flow, which are the primary reasons for its low overall score. Despite some positive corporate events, such as strategic acquisitions and partnerships, these have not yet mitigated the financial difficulties. The technical analysis suggests lackluster momentum, and the valuation metrics highlight the company’s unprofitable status, further weighing down the score.

To see Spark’s full report on TSE:TRUE stock, click here.

More about Treatment.com International

Treatment.com AI Inc. operates in the healthcare industry, focusing on leveraging artificial intelligence to enhance medical services. The company is known for its Global Library of Medicine and conversational voice applications, which aim to improve patient care and operational efficiency.

YTD Price Performance: -5.15%

Average Trading Volume: 18,190

Technical Sentiment Signal: Strong Buy

Current Market Cap: $17.89M

See more insights into TRUE stock on TipRanks’ Stock Analysis page.